Chi Heem Wong

Chi Heem Wong

Chi Heem Wong Prior to QLS, Chi Heem was completing his Ph.D. in Electrical Engineering and Computer Science (EECS) from Massachusetts Institute of Technology (MIT). His thesis presents computational methods to quantify risk in drug development programs, address...
Kien Wei Siah

Kien Wei Siah

Kien Wei Siah Prior to QLS, Dr. Siah was a research assistant at the MIT Laboratory for Financial Engineering where he developed better data analytics for drug development and designed novel business models to accelerate biomedical innovation. He has published in...
Andrew W. Lo

Andrew W. Lo

Andrew W. Lo Prior to QLS, Andrew W. Lo was Chairman and Chief Investment Strategist of AlphaSimplex Group. Andrew is also the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of MIT’s Laboratory for Financial Engineering, and...
John Frishkopf

John Frishkopf

John Frishkopf Prior to QLS, John Frishkopf was a founder of NewStar Financial, Inc. As the Treasurer and Head of Asset Management he developed NewStar’s risk management and securitization platform, issuing pioneering middle market collateralized loan obligations....
Shomesh E. Chaudhuri

Shomesh E. Chaudhuri

Shomesh E. Chaudhuri Prior to QLS, Sho was a postdoctoral associate at MIT’s Sloan School of Management where he helped design new funding vehicles and business models to access previously untapped pools of capital to support biomedical innovation. He has...